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ABSTRACT 
 
Proton beam therapy (PBT) is a state-of-the-art radiotherapy treatment approach that uses 
focused proton beams for tumor ablation. A key advantage of this approach over 
conventional photon radiotherapy (XRT) is the unique dose deposition characteristics of 
protons, resulting in superior healthy tissue sparing. This results in fewer unwanted side 
effects and improved outcomes for patients. Current available dosimeters are intrinsic, 
complex and expensive; hence cannot be used to determine the dose delivered to the 
tumor routinely. Here, we report a hydrogel based plasmonic nanosensor for 
measurements of clinical doses in ranges between 2-4 GyRBE. In this nanosensor, gold 
ions, encapsulated in a hydrogel, are reduced to gold nanoparticles following irradiation 
with proton beams. Formation of gold nanoparticles renders a color change to the 
originally colorless hydrogel. The intensity of the color can be used to calibrate the 
hydrogel nanosensor in order to quantify different radiation doses employed during 
treatment. The potential of this nanosensor for clinical translation was demonstrated 
using an anthropomorphic phantom mimicking a clinical radiotherapy session. The 
simplicity of fabrication, detection range in the fractionated radiotherapy regime and ease 
of detection with translational potential makes this a first-in-kind plasmonic colorimetric 
nanosensor for applications in clinical proton beam therapy. 
 
KEYWORDS: Protons, Gold nanoparticles, Hydrogel, Sensor, Colorimetric 
 
 
	 ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dedicated to my Parents, 
Hemant and Sangita Inamdar  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 iii 
ACKNOWLEDGMENTS 
I would like to start by thanking my advisor, Dr. Kaushal Rege for giving me this great 
opportunity to work on this exciting and upcoming field of radiation dosimetry for proton 
beam therapy. I am grateful for his support, guidance and inspiration and also his trust 
and belief in my abilities. His constant motivation and encouragement has definitely 
given me the push towards excellence. His deep involvement in the project was crucial in 
maintaining the pace at which I was working. I am truly blessed to have him has my 
mentor and guide, from whom I learnt the importance of hardwork and perseverance and 
also the value of discipline, punctuality and work ethic. I thank Dr. Rege for steering my 
career in the right direction. 
I would like to thank Dr. Aman Anand at Mayo Clinic Phoenix – Arizona, for kindly 
agreeing to serve on my thesis committee. His expertise and knowledge in the field was 
of great help to the project. He also helped me in understanding the basic concepts of 
proton therapy and also instrumental throughout the project with his insights to 
understand the length and depth of the project.  
I would also like to thank Dr. Brent Nannenga for agreeing to serve on my thesis 
committee. His help and inputs throughout the course of the project to put together my 
thesis was immense.  
I would also like to thank Dr. Martin Bues and Jarrod Lentz from Mayo Clinic Phoenix – 
Arizona, without whom this project wouldn’t have been possible. They extended their 
full support to use the facility whenever we wanted and also made the treatment plan 
needed for the experiments. 
	 iv 
 I would like to thank all the former and current members of Dr. Kaushal Rege’s lab from 
whom I learnt a great deal. It was an absolute pleasure to work with such a talented group 
of people: Karthik Pushpavanam Subramaniam, Dr. Taraka Sai Pavan Grandhi, Dr. Matt 
Christensen, Dr. Sudhakar Godesha, Dr. Sheba Goklany, Russ Urie, Rajesh Niti, 
Deepanjan Ghosh, Maryam Ridha, Mellika Meraji, Kevin Lin, Andy Dobos and Harini 
Murali. I would like to take to this opportunity to thank Karthik Subramaniam 
Pushpavanam, a PhD student in Dr. Kaushal Rege’s lab who was helped me throughout 
the project and without whom this study wouldn’t have been possible. 
I am very grateful to Ms. Bhoomika Sheth, Ms. Samruddhi Patil and Mr. Narayan 
Kanhere for their constant support throughout the course of my degree. 
I would also like to thank National Science Foundation grant to have funded this project. 
I would like to thank Fred Pena for helping in fixing equipment issues in lab. Without his 
help a lot of valuable research time would have been lost. I also gratefully acknowledge 
the use of facilities at the LeRoy Eyring Center for Solid State Science at Arizona State 
University, Tempe, AZ. 
Lastly, I am grateful to my parents for their constant support and encouragement 
throughout my life. Their belief in me has enabled me to pursue my dream.  
  
	 v 
TABLE OF CONTENTS 
               Page 
LIST OF TABLES…………………………………………………………………….…vii 
LIST OF FIGURES……………………………………………...……………..….........viii 
CHAPTER 
1. INTRODUCTION……………………………………………..………………..…….1 
1.1. Overview…………………………………………………………………….........1 
1.2. Literature Review……………………………………………...……………..…..2 
1.3. Motivation…………….……………………………………………..…………...4 
2. HYDROGEL NANOSENSOR FOR COLORIMETRIC DETECTION AND 
DOSIMETRY OF PROTON BEAMS……………...………………………………...6 
2.1. Introduction………………………………………………………………….........6 
2.2. Experimental…………………………………………………………………..….7 
2.3. Result and Discussion…………………………………………………………...11 
3. CONCLUSION AND FUTURE WORK…………………………...……………….35 
3.1. Conclusion………………………………………………………………………35 
3.2. Future work……………………………………………………………………...35 
4. REFERENCES…………………………………………………………………..…..37 
  
	 vi 
LIST OF TABLES 
 
Table               Page 
2.3.1. Actual and Experimental Dose Detection by Different Surfactants……………..33 
  
	 vii 
LIST OF FIGURES 
 
Figures              Page 
2.3.1. Schematic of Hydrogel Nanosensor Dosimeters for Proton Beam Therapy….…11 
2.3.2.  Images of Controls of Agarose Gels Acquired 2 hrs post a 2 GyRBE Radiation 
Dose without the Addition of Ascorbic Acid………………..…………………..14 
2.3.3. Image of Control of Agarose Gels Acquired 2 hrs post a 2 GyRBE Radiation Dose 
containing Only HAuCl4 without Ascorbic Acid and Surfactant………....…..…14 
2.3.4. Images of Hydrogel Nanosensors containing C10TAB Irradiated with Different 
Doses of Proton Beams …………………………...………………………..……15 
2.3.5. Images of Hydrogel Nanosensors containing C12TAB, C14TAB and C16TAB 
Surfactants with Different Proton Beams……………………….……………….16  
2.3.6. Transmission Electron Microscopy (TEM) Micrographs of Gold Nanoparticles 
with C12TAB as Surfactant …………………………………..………………....18  
2.3.7. Absorbance Spectra of Nanosensor Gels Containing C10TAB, C12TAB, C14TAB 
and C16TAB as Surfactants Post Irradiation with Proton Beams at Different 
Doses………………………………………………..……………………………19  
2.3.8. Kinetics of Gold Nanoparticles in Agarose Hydrogels with C10TAB, C12TAB, 
C14TAB and C16TAB with Protons………………………………………………23 
2.3.9. A Plot Depicting Maximum Absorbance vs Radiation Dose of the Nanosensor 
Gel containing C10TAB and C16TAB following Irradiation with Proton Beam 
Therapy………………..…………………………………………………………27  
 
 
	 viii 
Figures              Page 
2.3.10. A Plot Depicting Maximum Absorbance vs Radiation Dose of the Nanosensor 
Gel containing C12TAB and C14TAB following Irradiation with Proton Beam 
Therapy…………………………………………………………………...…….28 
2.3.11. Calibration Curve for C12TAB and C14TAB using Maximum Absorbance vs 
Proton Dose from 0 - 3 GyRBE……………………………..……………………30 
2.3.12. Evaluation of the Predictive Ability of Hydrogel Nanosensors using an 
Anthropomorphic Child Phantom placed on the Irradiation Table and Subjected to 
Proton Therapy…………………..…………………………………………...….32
	 1 
CHAPTER 1 
INTRODUCTION: 
1.1.Overview 
Radiation therapy is one of the primary treatment modalities employed for the ablation of 
various tumors in the clinic.1 Ideally, one can enhance therapeutic advantages of ionizing 
radiation by maximizing the sparing of the volume of healthy tissues that otherwise get 
exposed to XRT. At present, most external beam radiotherapy (EBRT) is administered 
using high-energy photons (e.g. X-rays), which characteristically deliver exit doses. As a 
result of which there is significant amounts of dose bath delivered to normal tissues lying 
either adjacent or towards the distal end of the target. This can lead to side effects, 
including radiation-induced toxicity, in healthy tissues2.  
 
Radiation doses are typically delivered in fractions of 2-5 Gy dose/day (conventional 
fractionated radiotherapy) leading to a cumulative dose in the range of 20 - 70 Gy for the 
entire treatment course (1 Gy = 1 Joule energy absorbed by a 1 kg mass)3, 4. Following 
the development of sophisticated imaging techniques and beam delivery modalities, 
proton beam therapy has found increased application in the treatment of cancer5. Proton 
beam therapy can therefore benefit from in vivo monitoring the dose delivered to 
different tissues during each fractionated treatment resulting in high efficacies and low 
toxicities. Currently employed dosimeters in the clinic (e.g. thermoluminescent diodes or 
TLDs, polymer gels, MOSFETs, radiographic film, etc.) require specialized equipment, 
can be cumbersome to operate, exhibit energy dependence, can require expensive 
fabrication processes, do not conform to human anatomical features, and / or use 
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sophisticated and expensive visualization modalities including magnetic resonance 
imaging (MRI).6-8 In many cases, they may also fail to provide information about the 
delivered dose at more than one point in the patient and the dose may be reported with 
insufficient spatial resolution. A novel dosimeter that can overcome these limitations, 
while demonstrating robust performance, can result in safe and effective monitoring 
radiation doses in proton therapy, potentially leading to improved patient outcomes. 
 
1.2. Literature Review 
Lately, gold and silver nanoparticles have found a lot of potential applications in 
biomedical field owing to their surface plasmon resonance properties9. Typically, these 
nanoparticle size ranges from 1 – 100 nm. These nanoparticles have been found to have a 
tendency of accumulating near tumor sites and hence have been used as imaging agents 
in radiation oncology. It has also been found that gold nanoparticles of optimal sizes can 
enhance CT imaging and radiotherapy in real time. Surface-enhanced Raman Scattering 
are enhanced because of the oscillating surface plasmons in these nanoparticles 
eventually resulting in increased efficacy of biological and chemical sensing. Stable free 
radicals are formed in amino acids can be detected using electron spin resonance (ESR)10. 
This free radical formation is induced when alanine powder and alanine blended with 
polymeric binders are used. These dosimeters are typically used when lower energies of 
the keV order are employed. The ESR signal response obtained is proportional to the 
number of free radicals formed and this in turn is used to report the radiation dose. 
Systems like these are widely used in biological dosimetry. They also serve as a reference 
point for commercially available dosimeters. Doping with high Z microscale materials 
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are found to enhance sensitivity of the alanine systems to X-rays11. This is because, 
incorporating the plasmonic particles in the matrix increase the dose enhancement factor 
(ratio of the mass absorption coefficient of the nanocomposite to that of pure alanine). 
These metallic nanoparticles, upon exposure contribute to an increase in the generation of 
free radicals within the alanine matrix. Nanocomposite powders were made by adding 
pre-synthesized nanoparticles to an aqueous alanine solution before drying at 40°C. 
When irradiated using a 90 keV beam, these nanocomposites displayed enhanced peak-
to-peak amplitude of the ESR spectra. Interestingly, when the nanoparticle concentration 
was increased from 0.01% to 1% AgNP, the DEF decreased. This could be attributed to 
agglomeration of particles at higher concentrations. Gold nanoparticles were seen to 
show the same behavior when employed. These nanocomposites with a linear response 
between 1 – 50 Gy have been seen to demonstrate nanoparticle size stability, improved 
sensitivity and homogeneity. Although ESR is a sophisticated detection technique, one 
limitation in this detection technique is that it requires trained professionals on 
specialized equipment. This can be a limitation in translating this technology towards 
clinical radiotherapy. 
 
Many nanoscale systems and molecules are being investigated as radiation dosimeters for 
conventional fractionated radiotherapy12. Although they exhibit potential for translation 
into clinical radiotherapy and implantable applications, additional studies have to be 
conducted on the reproducibility, biocompatibility, sensitivity, stability and/or toxicity of 
these systems. Recent studies carried out so far have demonstrated that only the 
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peripheral dose delivered is measured and there is no direct contact of the dosimeter with 
tissue13.  
 
1.3. Motivation 
 
Proton beam therapy is an alternate form of radiation therapy in which particles (protons) 
instead of high-energy photons are delivered to the tumor, potentially leading to greater 
control and precision over dose deposition at the disease site.14 This can lead to decreased 
damage to the surrounding tissue and hence fewer side effects post radiation treatment. 
This is primarily due to the unique dose deposition characteristics of protons known as 
the Bragg peak.15 As the protons enter the patient’s body they lose their kinetic energy in 
collisions with the electrons in the patient’s body. As the protons slow down their 
interaction cross section with electrons increases steadily until it reaches a sharp 
maximum shortly before the protons come to rest. This sharp maximum gives rise to the 
dosimetric Bragg peak.16  
 
The major advantage of protons over photons in conventional radiotherapy is that 
photons have a tendency to deposit energy throughout as they travel through the tissue 
whereas protons deposit maximum at a certain depth and lose their energy17. This was 
explained by William Bragg who found out that energy lost by the charged particle is 
inversely proportional to the square of its velocity. The velocity of the particles decreases 
as they travel through mass. The range of proton energy used gives a much flatter peak 
and hence can be used to target a larger volume of tumor. Hence, a maximum dose 
deposition occurs incase of proton therapy as compared to photons in radiotherapy. The 
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Linear Accelerator (LINAC) used in conventional radiation therapy for protons has a 
maximum dose depth limitation of 3 cm while the proton gantry used for proton beam 
irradiation can deliver a dose upto 32 cm. Also, when compared to X-ray beams, proton 
beams do not have an exit dose. Therefore, less damage is done to the surrounding tissues 
and hence less side effects from irradiation. 
 
In this work, a hydrogel based plasmonic nanosensor was made to detect therapeutic 
levels of radiation doses using proton beam therapy. The intensity of pink color seen 
because of the gold nanoparticles formed is used as an indicator representing each dose 
level. These gels were quantifies using UV-visible spectroscopy and a linear calibration 
curve was obtained for clinically relevant doses. Surfactants of different chain length 
were employed to optimize the system. The hydrogel system created was robust, less 
cumbersome and was able to be contoured according to the patient’s requirement.  
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CHAPTER 2 
INTRODUCTION 
 
Recent advances in molecular and nanoscale systems offer novel possibilities for 
radiation dosimeters7. Ionizing radiation causes formation of free radicals in water 
following hydrolysis. We employed this phenomenon in concert with effective 
templating molecules (e.g. aliphatic surfactants) to engender the formation of plasmonic 
(gold and gold-silver) nanoparticles from their respective metal ion formulations.12, 18-20 
The formation of plasmonic nanoparticles in liquid or gel formulations is accompanied by 
a visible color change which is distinct from the original metal ion formulation, which is 
colorless. Here, we report, for the first time, a colorimetric approach for the rapid 
detection of therapeutic levels (0-3 GyRBE) of proton irradiation. The extent of the color 
intensity depends on the dose of protons delivered to the gel and can be used for 
quantitative dose determination. To our knowledge, this is the first colorimetric 
nanosensor for detecting and predicting proton doses and has high potential for 
translation to clinical proton beam radiotherapy. 
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EXPERIMENTAL 
Materials. Gold(III) chloride trihydrate (HAuCl4.3H2O), decyltrimethylammonium 
bromide (C10TAB) (≥98.0%; non-aqueous titration grade), dodoceyltrimethylammonium 
bromide (C12TAB) (≥98%), myristyltrimethylammonium bromide (C14TAB) (≥99%), L-
ascorbic acid (AA) and agarose were purchased from Sigma-Aldrich. 
Cetyltrimethylammonium bromide (C16TAB) was procured from MP Chemicals. The 
chemicals received from the vendors were not purified further. MilliQ water (18.2 
MΩ.cm) was used as solvent for all experiments.  
 
Preparation of the Precursor Hydrogel. HAuCl4 (30 µL of 10 mM solution) was mixed 
with 600 µL of 50 mM solution of Cx=10,12,14,16TAB aliphatic surfactants, and 100 µL of 
the above mixture were discarded. Heated aqueous agarose (500 µL of 5% w/v) was 
added to the gold-surfactant solution. 24 well plates (diameter ~16 mm) were used to set 
the liquid mixture (650 µL) and form gels with a thickness of ~3 mm. Ascorbic Acid 
(650 µL of 10 mM solution) was allowed to diffuse into the gel for 10 minutes, resulting 
in the formation of translucent gel discs. These discs were used for irradiation studies as 
precursor hydrogels. 
 
Proton Beam Irradiation. All CT simulations of the phantom based setup and proton 
beam irradiations were conducted at the Proton Beam Therapy Center at Mayo Clinic 
Hospital, Phoenix, AZ. CT simulations were performed using the SOMATOM Definition 
AS (Siemens Healthcare, Erlangen, Germany), and spot-scanning based proton treatment 
plans were created using the Eclipse (Varian Medical Systems, Palo Alto, CA) treatment 
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planning system (version PCS 13.7) (TPS). Proton irradiations were delivered using the 
PROBEAT-V Proton Beam Therapy System (Hitachi, Ltd., Tokyo, Japan). Proton beam 
therapy doses are customarily prescribed and reported in relative biological effectiveness 
(RBE) - weighted absorbed dose (DRBE). In this work, in order to obtain physical dose 
D_RBE values may simply be divided by a constant factor of 1.1.  
 
Gel samples were placed in the inner wells of a 24-well plate, which was placed on the 
table with 5 cm-thick acrylic blocks placed above and below it. A CT simulation of the 
phantom was performed with slice thicknesses of 2 mm. A single Field Uniform Dose 
based treatment plan was designed in order to deliver 0.5 GyRBE uniformly across the 
central wells. The treatment was optimized such that the 99% of the dose reporting 
reference volume received 100% of the dose. In order to deliver larger doses to these gel 
samples, sequential treatment plans were generated by simply scaling the doses to higher 
DRBE levels: 0.5, 1.0, 1.5, 2.0, 3.0, 4.0 and 5.0 GyRBE. These doses delivered to our 
samples were validated with another reference film dosimeter. A piece of Gafchromic 
EBT3 film (Ashland, Bridgewater, NJ) was placed directly below the well plate during 
irradiation of the gel with 2.0 GyRBE.  Reference dosimetry using these calibrated 
gafchromic films matched the TPS calculated doses to within +/- 2.5%. While the 
irradiation times ranged between 41 seconds for the 0.5 GyRBE dose and 86 seconds for 
the 5.0 GyRBE dose, dose rate dependence of these dosimeters has not been investigated in 
this particular study. 
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Plasmonic Gel Dosimetry on an Anthropomorphic Child Phantom. A CT simulation, 
using a slice thickness of 1 mm and a pitch of 1.0, was performed on an ATOM 704 
anthropomorphic phantom (CIRS Inc., Norfolk, VA), which models a 1-year-old infant. 
Three radio-opaque markers were placed at isocenter, and two more were placed at the 
head and foot to ensure a reproducible setup. A plan was created whereby a posterior-
anterior field was used to deliver a prescription DRBE of 1.8 GyRBE to a target 
encompassing the spine. The phantom was irradiated with gel samples placed on the table 
at various points beneath it, providing a measurement of the skin dose to the phantom.  
 
Absorbance Spectroscopy. Following irradiation with different proton doses, the 
absorbance spectra of the gel samples were measured for wavelengths ranging from 300 
to 990 nm with a step size of 10 nm using a BioTek Synergy 2 plate reader. All 
absorbance measurements were carried out at 2 hours following irradiation, because the 
travel time from the Mayo Clinic to ASU can vary. However, the color change was seen 
as early as 15 minutes post irradiation in most cases. The absorbance values obtained 
were offset by subtracting the wavelength at 990 nm. The peak between 500-600 nm was 
used as an indicator for the formation of gold nanoparticles. A maximum absorbance 
value between 500-600 nm vs. proton dose was plotted for all surfactants.  
 
Image Processing. A Canon EOS 1100D camera was used to acquire all gel images. The 
Fotor Photo Editor application was used to crop the images to the desired size, but no 
further editing was carried out. All pictures reported in this article were acquired for 
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visualization alone and not used for quantification of the dose response, which was 
carried out using absorbance analysis.  
 
Transmission Electron Microscopy. The irradiated sample was kept at room 
temperature overnight for air drying. The dried sample was soaked in epoxy resin. Thin 
slices of the cured epoxy-containing sample were sectioned using an ultramicrotome. 
These thin samples were imaged using a Philips CM 12 Transmission electron 
microscope.  
 
Statistical Analyses. All experiments were carried out in triplicate unless otherwise 
stated. Statistical analysis calculations were carried out using Microsoft Excel and data 
are expressed as the mean of these independent experiments ± one standard deviation. 
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RESULTS AND DISCUSSION 
The ability to detect proton doses administered to tissues can have significant 
implications for improving treatment outcomes in radiotherapy. To this end, a robust 
nanosensor that can reliably detect doses at the intended target as well as nearby tissues 
can enhance the efficacy of radiotherapy, which can lead to improved patient outcomes. 
Here, we report our studies on a gel-based colorimetric nanosensor that can detect doses 
employed for fractionated proton radiotherapy in the clinic. The nanosensor works on the 
principle that exposure of a precursor hydrogel to high-energy radiation (e.g. photons) or 
particles (e.g. protons) results in the formation of free radicals upon hydrolysis (water 
splitting), which, in turn, reduce the encapsulated gold ions to gold nanoparticles within 
the matrix (Figure 2.3.1.).12, 19  
 
 
 
 
Agarose 
gel 
Nanosensor 
precursor 
Gel 
dosimeter 
post 
10 min 
incubation  
Ascorbic 
Acid 
During 
Irradiation 
Proton 
Gantry 
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Figure 2.3.1. Schematic of hydrogel nanosensor dosimeters for proton beam therapy. 
Cylindrical hydrogel discs, 16 mm diameter and 3 mm height, are formulated with 10 
mM HAuCl4, 50 mM CxTAB (x=10, 12, 14 or 16) and 5% (w/v) agarose. Just prior to 
irradiation, 10 mM ascorbic acid is added from the top and allowed to diffuse into the gel 
for 10 minutes. A characteristic maroon color is seen post irradiation due to formation of 
gold nanoparticles within the gel matrix. 
 
Initially, gold exists as trivalent Au(III) ions along with the cationic surfactant molecules 
within the heated agarose solution. These Au(III) metal ions are then reduced to 
monovalent Au(I) ions using ascorbic acid as the reducing agent.21 The reduction 
potential of Au(I) is higher than that of Au(III), which increases the thermodynamic 
favorability of zerovalent gold ion or Au(0) formation.22, 23 These Au(0) ions are thought 
to nucleate and grow to form gold nanoparticles; the cationic surfactant used in the 
formulation (CxTAB; x=10, 12, 14, or 16) likely stabilizes the gold nanoparticles formed 
and may also play a role in templating the nanoparticles.  
 
Irradiation of Au(I)-containing agarose gels with high-energy proton particles can 
facilitate splitting of water molecules in the hydrogel, which, in turn, can result in the 
formation of e-, H. and OH. free radicals.24 Of these, e- and H. are reducing in nature and 
help reduce Au(I) ions to zerovalent Au(0) ions. Ascorbic acid, an antioxidant, is thought 
to help quench the oxidizing OH. radicals formed in the process,25 which can further 
enhance the efficacy of nanoparticle formation. The agarose hydrogels are initially 
translucent and colorless prior to irradiation, but change color to maroon once exposed to 
protons due to formation of gold nanoparticles within the matrix, resulting in a visible 
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indicator of proton therapy doses. Surfactants of different chain lengths (Cx, where x=10, 12, 14, 
or 16TAB) were employed to facilitate the formation of gold nanoparticles. Water 
solubility, biocompatibility and ease in formulation of hydrogels were some of the major 
factors influencing the selection of agarose as the gel matrix.  
 
A number of control experiments were carried out in order to investigate the performance 
of the gel nanosensor system. An intense yellow color of the hydrogel was observed 
following the mixture of HAuCl4 and CxTAB (x=10,12,14 or 16) with heated agarose. 
The observed color is caused by the ligand exchange of Cl- in AuCl4- to Br- present in 
CxTAB.22 It is likely that AuBr4- exists as stable CTA-AuBr4- metallomicelles within the 
agarose matrix.22 Ascorbic acid reduces AuBr4- to AuBr2-, which indicates conversion of 
gold ions from the trivalent Au(III) state to the monovalent Au(I) state.26 Ascorbic acid is 
a weak reducing agent, and thus only partial reduction of the gold (from Au(III) to Au(I)) 
is possible in the presence of a high concentration of the surfactant. This is because the 
oxidation potential of the ascorbic acid reduces in micellar environments.27 The yellow-
colored hydrogels turn colorless once ascorbic acid is added to the hydrogel, which is the 
precursor hydrogel used in all proton irradiation studies. We suggest that the presence of 
micelles in our hydrogel system leads to enhanced shielding between Au+ ions and 
ascorbic acid, which retards spontaneous nanoparticle formation.  
 
Irradiation of agarose hydrogels containing HAuCl4 and CxTAB with protons in the 
absence of ascorbic acid did not induce any color change to the hydrogel (Figure 2.3.2). 
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Figure 2.3.2. Images of controls of agarose gels acquired 2 hrs post a 2 GyRBE radiation 
dose containing 10 mM HAuCl4 and 50 mM Cx=10,12,14&16TAB surfactant (From Left to 
Right). No change in color was observed post irradiation. Ascorbic acid was not used in 
any of the gel formulations. 
 
Similarly, irradiation of gels containing a mixture of HAuCl4 and agarose alone (no 
ascorbic acid or CxTAB) did not result in a change in color (Figure 2.3.3).  
 
 
 
 
Figure 2.3.3. Image of control of agarose gels acquired 2 hrs post a 2 GyRBE radiation 
dose containing only 10 mM HAuCl4. No change in color was observed post irradiation. 
Ascorbic acid was not used in any of the gel formulations. 
 
These results indicate that all components - HAuCl4, CxTAB, ascorbic acid (AA) and 
agarose - play a key role in the formulation of the plasmonic hydrogel based nanosensor 
for detecting proton doses. Interestingly, we observed that C10TAB shows a slight 
development of color, which indicates spontaneous nanoparticle formation even in 
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absence of radiation. C10TAB (CMC ~ 65mM) does not form micelles at concentrations 
employed (~25mM) in the current system.28 This likely leads to low steric hindrance and 
allows for spontaneous nanoparticle formation, which can be visually observed (Figure 
2.3.4.).   
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3.4. Images of hydrogel nanosensors containing 50 mM C10TAB 
irradiated with different doses of proton beams as indicated. All gels contain 10 mM 
HAuCl4 and 10 mM ascorbic acid. All images were taken 2 hours after irradiation of gels 
with protons. 
 
All surfactants employed were able to facilitate and template the formation of gold 
nanoparticles when exposed to the therapeutic doses of proton irradiation (0-5 GyRBE). A 
0 GyRBE 0.5 GyRBE 1 GyRBE 
2 GyRBE 3 GyRBE 4 GyRBE 5 GyRBE 
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characteristic maroon color of gold nanoparticles was visible post irradiation in the 
hydrogels (Figures 2.3.5.). 
 
(A) 
 
 
 
 
 
 
 
 
 
 
(B) 
 
 
 
 
 
 
 
 
0 GyRBE 0.5 GyRBE 1 GyRBE 
2 GyRBE 3 GyRBE 4 GyRBE 5 GyRBE 
0 GyRBE 0.5 GyRBE 1 GyRBE 
2 GyRBE 3 GyRBE 4 GyRBE 5 GyRBE 
	 17 
 
 
 
(C) 
 
 
 
 
 
 
 
 
Figure 2.3.5. Images of hydrogel nanosensors containing (A) 50 mM C12TAB, (B) 50 
mM C14TAB and (C) 50 mM C16TAB surfactants, irradiated with different doses of 
proton beams as indicated. All gels contain 10 mM HAuCl4 and 10 mM ascorbic acid. 
All images were taken 2 hours after irradiation of gels with protons. 
 
The color in the hydrogels irradiated with doses more than 1 GyRBE was visually 
observable 10 min. after exposure to radiation. Low dose (0.5 GyRBE and 1 GyRBE) 
irradiation required longer times (~ 20 min.) for development of the maroon color. The 
increase in color intensity is directly dependent on the generation of free radicals which 
increases as the dose of the proton irradiation increases. This results in an increase in the 
formation of gold nanoparticles upon irradiation. Formation of gold nanoparticles was 
further visualized using transmission electron microscopy (TEM; Figure 2.3.6.); non-
0 GyRBE 0.5 GyRBE 1 GyRBE 
2 GyRBE 3 GyRBE 4 GyRBE 5 GyRBE 
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homogenous particle distribution was observed with particles ranging from 20-100nm in 
diameter. 
 
(A)       (B) 
 
 
Figure 2.3.6. Transmission Electron Microscopy (TEM) micrographs of gold 
nanoparticles with C12TAB as surfactant irradiated with 2GyRBE radiation dose. (A) Low-
magnification image depicting presence of gold nanoparticles in the dried hydrogel. (B) 
High-magnification image of the highlighted region in Figure A. 
 
The absorbance of hydrogels was quantified using UV-vis spectroscopy, 2 hours post 
irradiation with protons (Figure 2.3.7.). A characteristic spectral peak corresponding to 
the presence of gold nanoparticles was observed at ~520nm.  
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(D) 
 
 
 
Figure 2.3.7. Absorbance spectra of nanosensor gels containing (A) C10TAB, (B) 
C12TAB, (C) C14TAB and (D) C16TAB as surfactants post irradiation with proton beams 
at different doses. Gold nanoparticle formation is indicated by a characteristic peak 
between 500 – 600 nm. 
 
No change in color was observed for up to 4 hours, indicating stability of the generated 
nanoparticles over time (Figure 2.3.8.); gold nanoparticles are known to be stable and we 
do not anticipate change in the color over longer durations.  
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(D) 
 
 
 
Figure 2.3.8. Kinetics of gold nanoparticles in agarose hydrogels with (A) C10TAB, (B) 
C12TAB, (C) C14TAB and (D) C16TAB with protons. Absorbance spectra was measured 
after 2 hrs post irradiation with the maximum absorbance (between 500 – 600 nm) plotted 
against time to generate the plot. 
 
A correlation between the administered proton radiation dose and maximum absorbance 
was plotted between 0 - 5 GyRBE (Figure 2.3.9. and 2.3.10.), which is a range commonly 
used in conventional fractionated proton beam therapy.  
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Figure 2.3.9. Absorbance spectra of the nanosensor gel following irradiation with proton 
beam therapy; A plot depicting maximum absorbance vs radiation dose 2 hrs post 
irradiation is shown. The formulation of gels with (A) yellow squares representing 
C10TAB surfactant while (B) grey diamonds representing C16TAB with 10 mM HAuCl4 
and 10 mM ascorbic acid with 5% agarose is shown in the plot. 
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Figure 2.3.10. Absorbance spectra of the nanosensor gel following irradiation with 
proton beam therapy; A plot depicting maximum absorbance vs radiation dose 2 hrs post 
irradiation is shown. The formulation of gels with (A) blue circles representing C12TAB 
surfactant while (B) orange triangles representing C14TAB with 10 mM HAuCl4 and 10 
mM ascorbic acid with 5% agarose is shown in the plot. 
 
Reaction volumes on the nanoscale can enhance reaction rates of e-aq generated upon 
radiolysis with [AuBr2]- ions attached to the head group of the micelle. It has been 
previously reported that the efficiency of charge transfer was enhanced in presence of 
cationic micelles (hexadecyltrimethylammonium bromide or CTAB micelles and a 
mixture of CTAB and cetylpyridinium or CP micelles) compared to anionic micelles.29 It 
was hypothesized that the hydrated electrons were more easily transported in the solvent, 
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possibly due to the favorable attractive force between this negatively charged species and 
cationic micelles.30 This attractive force can lead to an increased probability of capture of 
hydrated electrons by the micelle and reaction with [AuBr2]-. When these electrons 
interact with an empty site (i.e. no Au+ is present), an electron hopping / migration 
mechanism can facilitate intermicellar reaction between Au+ ions and hydrated electrons 
leading to the formation of Au0 atoms.31  
 
Compared to C10TAB and C16TAB, C12TAB and C14TAB showed higher efficacies of 
nanoparticle formation, as indicated by the maximum absorbance determined for a given 
radiation dose. In absence of micelles, hydrated electrons are not influenced by the 
positive field and hence recombine and participate in secondary chemical reactions 
before reacting with Au+ ions. This leads to a reduced yield of Au0 atoms which, in turn, 
results in low yields of gold nanoparticles. In our current formulation, C10TAB does not 
form micelles, and it has a tendency to form a lower yield of nanoparticles under ionizing 
irradiation compared to CxTAB (x=12, 14). C16TAB has a stronger positive electrostatic 
field compared to the other surfactants employed in the study due to the higher 
aggregation number required to form a micelle.32 The availability of hydrated electrons 
for reducing Au+ ions is significantly reduced under the influence of a strong electrostatic 
field. This results in lower yields of zerovalent Au0 ions, which, in turn, is responsible for 
lower yields of gold nanoparticles. Experimentally, this is captured by the lower 
absorbance values seen in case of C16TAB compared to C12TAB or C14TAB under 
similar irradiation conditions. We suggest that C12TAB and C14TAB form micellar 
nanostructures with surface charge characteristics that are necessary for facilitating the 
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formation of gold nanoparticles in gels in a dose-dependent manner following proton 
irradiation.   
 
We next evaluated the performance of our nanosensor with C12TAB or C14TAB 
formulated in the agarose gel. A linear correlation between gold nanoparticle absorbance 
and radiation dose was found in the range of 0 – 3 GyRBE for both C12TAB and C14TAB 
(Figure 2.3.11.).  
 
 
 
 
Figure 2.3.11. Calibration curve for C12TAB (blue dotted line) and C14TAB (orange 
dotted line) using maximum absorbance vs proton dose from 0 - 3 GyRBE, 2 h post 
irradiation. 
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The calibration curve with C12TAB had a correlation of y=0.069x, while that with 
C14TAB was y=0.074x. A test dose of 1.5 GyRBE was delivered to the gel to investigate 
the predictive ability of these calibrations. The color change of this test gel was 
quantified 2 hours post irradiation using the resepctive calibrations, which indicated a 
dose of 1.8 ± 0.44 GyRBE for the C12TAB gels and 2.1 ± 0.1 GyRBE for the C14TAB 
surfactant gels, indicating better predictive ability of the C12TAB gels. 
 
An anthropomorphic child phantom was used to investigate the translational potential of 
the plasmonic nanosensor hydrogel (Figure 2.3.12). Gels with C12TAB or C14TAB 
surfactants were employed in the phantom studies, because of the better calibration 
curves obtained with these surfactants compared to the others. The gels were placed 
within the defined field under the spine of the phantom (Figure 2.3.12.) and subjected to 
a dose of 1.8 GyRBE,; the respective calibration curves from 0-3 GyRBE were used for 
estimation of the dose delivered.  
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(A) 
 
 
 
(B) 
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Figure 2.3.12. (A) Evaluation of the predictive ability of hydrogel nanosensors using an 
anthropomorphic child phantom placed on the irradiation table and subjected to proton 
therapy. (B) an X-ray computed tomography (CT) scan image of the phantom used in the 
experiments. The spinal cord of the phantom is irradiated with 1.8 GyRBE.  
 
 
 
Surfactant 
 
Actual Dose 
Delivered (GyRBE) 
Average Dose 
Delivered ±  
one S.D. (GyRBE) 
 
C12TAB 
 
1.8 
 
1.6 ± 0.2 
 
C14TAB 
 
1.8 
 
1.4 ± 0.4 
 
 
Table 2.3.1. The table indicates the dose delivered to each of the surfactants employed in 
the experiments and the average dose calculated using the C12TAB and C14TAB-based 
hydrogel nanosensors. 
 
C
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A prediction of 1.6 ± 0.2 GyRBE was made using the calibration curve for C12TAB, and a 
prediction of 1.4 ± 0.4 GyRBE was made using the calibration curve for C14TAB 
calibration curve, respectively (Table 2.3.1.). Our nanosensor hydrogel with C12TAB 
surfactant shows an 11% error to the true value of the dose delivered (i.e. 1.8 GyRBE). 
Clinically used MOSFETs have been found to give an error percentage of ± 5% which is 
comparable to our current system.33 The clearly visible color change, simple detection 
technique using absorbance spectroscopy, and the ability to quantitatively predict doses 
demonstrates the potential of the hydrogel nanosensor for dosimetry in fractionated 
proton beam radiotherapy in the clinic. 
  
	 35 
CHAPTER 3 
 
CONCLUSIONS 
Conclusion 
To our knowledge, we have developed the first gel-based colorimetric nanosensor for 
detecting and predicting the dose delivered in proton beam therapy. The hydrogel 
nanosensor was able to detect doses as low as 0.5 GyRBE and showed a robust linear range 
between 0-3 GyRBE. The gel nanosensor was able to predict the dose delivered to an 
anthropomorphic child phantom with significant accuracy, indicating promise for 
translation to the clinic. In addition to the simple, visible, stable and quantifiable nature 
of the readout, the hydrogel system can be contoured for patient personalized treatments. 
We believe that this one-of-a-kind nanosensor holds high promise for translation to 
clinical proton beam therapy. 
 
Future Work 
Agarose and ascorbic acid are generally regarded as safe, and C16TAB is used in 
antibacterial formulations used on skin.34 
• Although the surfactants used in the formulation of the gels can be toxic at 
elevated concentrations, use of secondary containment devices or eventual 
replacement of the surfactant with biocompatible templating molecules will 
alleviate these concerns.  
• The development of a new generation of cationic surfactants that allow for 
precise control of nanoparticle size and yields can lead to sensors with improved 
prediction abilities. 
	 36 
• Patterning nanoparticles post irradiation for spatial dose detection. 
• Use of the hydrogel dosimeters in endorectal balloons and SpaceOARs. 
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